AbbVie
ABBV
#25
Rank
HK$4.060 T
Marketcap
HK$2,297
Share price
-0.59%
Change (1 day)
26.29%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): HK$45.84

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$45.91. In 2025 the company made an earnings per share (EPS) of HK$18.57 a decrease over its 2024 EPS that were of HK$19.00.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$45.84146.79%
2025HK$18.57-2.26%
2024HK$19.00-11.86%
2023HK$21.56-58.95%
2022HK$52.522.49%
2021HK$51.25121.58%
2020HK$23.13-44.7%
2019HK$41.8245.84%
2018HK$28.689.72%
2017HK$26.14-9.54%
2016HK$28.8916.28%
2015HK$24.85184.1%
2014HK$8.75-57.15%
2013HK$20.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.36 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.36 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$18.52-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.32-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.86 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$22.57-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$54.68 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA